New bedside test to guide warfarin dosing for heart patients
Part of Blood & lymphatic clinical trials.
This study tests whether a new bedside test (point-of-care testing) can help doctors give you the right dose of warfarin more quickly and safely. If you are starting warfarin for the first time and are in the hospital for a heart problem, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the hospital for a heart condition and are starting warfarin for the first time—and you will need it for at least 3 months.
- You do not have a known gene test result for CYP2C9 or VKORC1 (the genes that affect warfarin).
- You do not have a bleeding problem, severe liver or kidney disease, or an active cancer.
- You are not pregnant or nursing, and your blood pressure is under control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test called ClotChek™ to see how well it works for people taking direct oral anticoagulants (DOACs), a type of blood thinner. You would give a blood sample, and the test may help doctors better monitor your medication.
This study measures how long it takes for your blood to clot while you are taking anticoagulant medication. The purpose is to understand typical clotting times for patients on these drugs, which may help improve future monitoring or treatment decisions.
This study tests a new quick blood-clotting test (point-of-care INR testing) for patients with antiphospholipid syndrome who take blood thinners. The goal is to see if this faster test works as well as standard lab tests for monitoring their treatment.
This study tests a better way to manage warfarin (a blood thinner) for people with atrial fibrillation (an irregular heartbeat). The goal is to improve treatment and help prevent stroke.
This study looks at why some people process warfarin (a blood-thinning medicine) differently. It aims to learn what personal or medication factors may affect how well warfarin works, so future dosing can be safer and more accurate.
This study collects blood samples from people who take warfarin to help improve monitoring of the medication. It is designed for patients who are stable on warfarin and want to contribute to research.
Hear when a new Anticoagulation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.